Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...

The following is a summary of “Characteristics of scrotal involvement in IgA vasculitis: Relationship with disease activity ...

The U.S. Food and Drug Administration (FDA) approved Kamada's application to manufacture CYTOGAM in May 2023. During the year ...

Patients with moderate to severe chronic spontaneous urticaria that were antihistamine-resistant to omalizumab experienced ...

Twist Bioscience Corporation’s TWST share price has dipped by 8.55%, which has investors questioning if this is right time to buy.

New research links HPV to thyroid eye disease, suggesting viral infection may trigger immune responses through molecular ...

The European Medicines Agency (EMA) has recommended marketing authorization for Tepezza (teprotumumab) for adults with ...

The Vietnam plasma fractionation market has demonstrated substantial growth, with its valuation increasing from $56.62 million in 2019 to an anticipated $79.03 million by 2027. Th ...